Gerontology & Geriatrics
Artificial intelligence for aging research in cancer drug development
A new editorial paper was published in Aging, entitled, "Artificial intelligence for aging research in cancer drug development."
Dec 7, 2023
0
0
Page 11 - News tagged with cancer drug development
Oncology & Cancer
Scientists decipher 3-D structure of a promising molecular target for cancer treatment
Columbia University scientists, in collaboration with researchers from Nimbus Therapeutics, have demystified a metabolic enzyme that could be the next major molecular target in cancer treatment.
Apr 3, 2019
0
34
Oncology & Cancer
Clinical trial tests feasibility of targeting particular classes of tumor types with certain drugs
A large team of researchers from the U.S., Spain and Australia has found that the efficacy of drugs for treating cancer aimed at targeting particular classes of mutations depends on the type of tumor tissue involved and the ...
Oncology & Cancer
Cancer drugs: better, cheaper
Cancer drug development is known to be too slow, costly and fraught with failure. Now the U.S. Food and Drug Administration is issuing recommendations for breast cancer trials that would substantially accelerate patient access ...
Jun 4, 2012
0
0
Medications
Predicting correct dosage may improve success of drug repurposing
Before a drug can be used to treat a disease, it must go through a lengthy and expensive trial process to prove both safety and effectiveness. By repurposing already-approved drugs, researchers can cut out the time and expense ...
Jan 12, 2024
0
12
Oncology & Cancer
Key protein's newly discovered form and function may provide novel cancer treatment target
Research led by St. Jude Children's Research Hospital investigators suggests that safeguarding cell survival and maintaining a balanced immune system is just the start of the myeloid cell leukemia sequence 1 (MCL1) protein's ...
Apr 30, 2012
0
0
Oncology & Cancer
Gene mutations coordinate to drive malignancy in lung cancer
Scientists have shown exactly how mutations in two different genes coordinate to drive the development of malignant lung tumors, according to a new report in the open-access journal eLife.
Aug 27, 2019
0
6
Other
MD Anderson and Bayer collaborate to create symptom assessment questionnaires in clinical trials
When cancer patients take part in a clinical trial to develop new therapies, they and their physicians want to know how they will feel and function during treatment. A new collaboration between Bayer and The University of ...
Jan 23, 2015
0
13
Oncology & Cancer
Novel anti-cancer drug, ONC201, focus of alliance between Oncoceutics and MD Anderson
Oncoceutics Inc. and The University of Texas MD Anderson Cancer Center today announced the initiation of a strategic alliance and research collaboration agreement for the clinical development of ONC201, a novel anti-cancer ...
Jan 5, 2015
0
10
Genetics
'CYCLOPS' genes may serve as an Achilles' heel in tumor cells
BOSTON--The genomic tumult within tumor cells has provided scientists at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard with clues to an entirely new class of genes that may serve as an Achilles' ...
Aug 15, 2012
0
0
